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ABSTRACT 
 
A 4-year-old 4-kg male Yorkshire Terrier was brought for a re-evaluation of 
inflammatory bowel disease (IBD) diagnosed two years before. The dog presented with a four-
week history of diarrhoea, biliary vomiting, weight loss and ascites. Laboratory analysis revealed 
hypoproteinemia and a neutrophilic leucocytosis. An upper gastrointestinal endoscopic 
examination was performed. During the endoscopic procedure, the animal died due to a 
cardiopulmonary arrest. The necropsy confirmed the presence of a pulmonary 
thromboembolism. Extraintestinal manifestations of IBD are well reported in humans, but rarely 
appear in dogs. In Human Medicine, a very common extraintestinal manifestation of IBD is the 
presence of thromboembolisms. Further studies are needed to evaluate the tromboembolism risk 
in dogs with IBD.  
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RESUMEN 
 
Se describe el caso clínico de un perro macho de raza Yorkshire de 4 años de edad que 
acude a la consulta para una revisión de su enfermedad inflamatoria intestinal (EII) diagnosticada 
hace 2 años. El animal se presenta con una historia de diarrea, vómitos biliosos, pérdida de peso 
y ascitis de 4 semanas de duración. Los análisis de sangre mostraron la presencia de 
hipoproteinemia y leucocitosis. Se lleva a cabo una exploración endoscópica del tracto digestivo 
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superior durante la cual el animal muere. El examen postmortem confirma la presencia de un 
tromboembolismo pulmonar. Las manifestaciones extraintestinales de la EII se describen con 
frecuencia en humanos pero no en perros. Entre estas, los tromboembolismos son muy 
frecuentes en medicina humana. Sería de interés realizar más estudios con el fin de profundizar 
en el riesgo de la aparición de tromboembolismos en perros con EII. 
PALABRAS CLAVE: Enfermedad inflamatoria intestinal (EII), tromboembolismo pulmonar, 
perro, ascitis. 
 
Inflammatory bowel diseases (IBD) are a group of idiopathic disorders characterized by 
the presence of gastrointestinal clinical signs and histological evidence of intestinal inflammation 
(Guilford 1996).  
The most frequent clinical signs of IBD in the dog are chronic diarrhoea, vomiting, 
weight loss, anorexia or polyphagia. In human medicine, many extraintestinal signs have been 
described in the literature; however, in veterinary medicine, they are rarely reported (Guilford 
1996a). Polyarthritis (Pedersen et al 1976, Bennet 2005), inflammatory hepatic disease, 
pancreatitis, nephritis (Weiss et al 1996) and polydipsia (Henderson and Elwood 2003) have 
been detected in small animals with IBD. Thrombocytopenia and anaemia have also been 
reported (Ridgway et al 2001, Ristic and Stidworhty 2002). The pathogenesis of these 
extraintestinal signs is not well understood; immunoregulatory defects have been related with 
some of these extraintestinal signs (Ridgway et al 2001).  
The occurrence of thromboembolisms is a serious complication in human IBD (Talbot et 
al 1986, Jackson et al 1996). Deep vein thrombosis of the leg and pulmonary emboli are the 
most frequent events (Talbot et al 1986). The aetiopathogenesis of these complications has been 
widely discussed, being the presence of hypercoagulable state as the suggested cause for 
thromboembolism in humans with IBD (Schapira et al 1999).  
Here we describe a clinical case of pulmonary thromboembolism in a dog with IBD 
associated with a protein-losing enteropathy.  
 
CASE DESCRIPTION 
 
A 4-year-old 4-kg sexually intact male Yorkshire Terrier was referred to the Veterinary 
Medicine Teaching Hospital of the Complutense University of Madrid for a re-evaluation of 
inflammatory bowel disease.  
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Two years before, the dog presented with chronic diarrhoea, biliary vomiting, weight 
loss, and ascites. Blood analysis showed hypoproteinemia (plasma proteins: 3.1 g/dL, albumin: 
1.7 g/dL). A histopathological study of endoscopic biopsies had shown a severe lymphocytic-
plasmacytic infiltrate in the duodenum, edema in the lamina propria and lymphangiectasia. The 
dog was initially treated with prednisone  (1 mg/kg PO q12 hours for 10 days, 0.5 mg/kg PO q12 
hours for 10 days, 0.5 mg/kg PO q24 hours for 10 days, and 0.5 mg/kg PO q48 hours for 60 
days), and metronidazole  (10 mg/kg PO q12 hours for 21 days). Dietary management using a 
prescription diet for gastrointestinal disease  was administered. 
Clinical response after therapy was favourable, obtaining normal values of plasma 
proteins and albumin after treatment. No medical therapy was administered for two years. 
Clinical signs were absent for this period of time, until a four-week history of chronic diarrhoea, 
biliary vomiting, weight loss and ascites was presented. At that time, physical examination 
revealed some abnormal findings: rectal temperature 36.7ºC, slight dehydration (4%), and 
ascites. Pulse, capillary refill time, and heart and pulmonary sounds were normal. No jugular 
pulses were detected. Blood analysis showed: PCV: 47%, hemoglobin: 15.5 g/dL, RBC count: 
6.85x106/μL, platelets: 420x103/μL, WBC count: 21.3x103/μL, neutrophils: 20.4x103/μL, 
lymphocytes: 0.4x103/μL, eosinophils: 0.4x103/μL, glucose: 97 mg/dL, urea: 55 mg/dL, 
creatinine<0.5 mg/dL, total protein: 2.8 g/dL, albumin: 1.9 g/dL, ALT: 15 IU/L, alkaline 
phosphatase: 63 IU/L, Na+: 137 mmol/l, K+: 3.7 mmol/l, Cl-: 103 mmol/l, fibrinogen: 116 
mg/dL. Prothrombin time (PT) and activated partial thromboplastin time (APTT) were normal; 
antithrombin III was not evaluated. Serology for Leishmania infantum and Ehrlichia canis was 
negative. Urine analysis was normal. Protein/creatinine ratio was 0.09 g/mmol. 300 ml of 
abdominal fluid were removed and analyzed; the specific gravity was of 1.008, total proteins 
value was 200 mg/dL, 12 nucleated cells/μL were found, and lipids and bacteria were absent. 
Examination of faeces for parasites was negative. Abdominal ultrasound revealed a significant 
thickening of the small bowel wall (> 6 mm), though the layered appearance of the bowel wall 
was maintained.  
An upper gastrointestinal endoscopic examination was planned. Metronidazole  (10 
mg/kg BID) and Hetastarch  (20 ml/kg/day IV) were administered for one day prior to the 
procedure. Pre-anaesthetic electrocardiography was normal. An IV bolus of fentanyl  (10 μg/kg) 
and diazepam  (0.2 mg/kg) was administered as pre-anaesthetic. Isoflurane  was used for 
induction (5% MAC) and maintenance (0.5% MAC). The endoscopy revealed erythemic mucosa 
with a granular appearance and some erosions in the stomach, and erythemic, granular, irregular 
García-Sancho M. et al. Revista Complutense de Ciencias Veterinarias 4 (2) 2010: 78-86 
 
81 
and friable mucosa in the duodenum. A cardio-respiratory arrest occurred while finishing the 
endoscopic procedure, and resuscitation manoeuvres were unsuccessful.  
Subsequent necropsy revealed a poor body condition, presence of yellowish-fluid in the 
abdominal cavity, and a severe thickening of the gastric and bowel wall. Some erosions were 
present in the gastric body and pyloric antrum. Lymphangiectasia was observed in different 
points of the small bowel (Figure 1). The most important finding in thorax cavity was a 
thrombosis in the pulmonary artery (Figure 2).  
The histopathological study of the endoscopic biopsies revealed a moderate lymphocytic-
plasmacytic infiltrate in the duodenum, severe oedema in the lamina propria and marked 
lymphangiectasia. Histopathology of the liver and kidneys didn’t show any significant lesion. 
 
 
 
 
 
 
 
 
Figure 1.- Bowel lymphangiectasia on the serosa.               Figure 2.- Thrombus attached to the pulmonary artery. 
 
DISCUSSION 
 
In human medicine, many extraintestinal manifestations of IBD have been reported, such 
as musculoeskeletal signs, specially arthritis and ankylosing spondilitis (Rankin 1990, Levine 
and Lukawski-Travish 1995, Bernstein et al 2001). Other alterations commonly associated to 
human IBD are ocular signs (iritis/uveitis), hepatobiliary signs (primary sclerosing cholangitis), 
and cutaneous signs (pyoderma gangrenosum, and erythema nodosum) (Rankin 1990, Levine 
and Lukawski-Travish 1995, Bernstein et al 2001). Neurological (Lossos et al 1995), respiratory 
(Mahadeva et al 2000), urinary (Wester et al 2001), cardiac (Hyttinen et al 2003), and pancreatic 
alterations (Huang and Lichtenstein 2002) have also been described. 
Thromboembolic events and other vascular and haematological signs have been 
described in humans with this disease (Talbot et al 1986, Jackson et al 1997, Novaceck et al 
1999). Both Crohn’s disease and ulcerative colitis are thought to be associated with a high risk of 
thromboembolisms (Bernstein et al 2001). In fact, the risk of developing deep venous thrombosis 
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or pulmonary embolism is three times higher in patients with IBD (Bernstein et al 2001). This 
risk is especially higher in young patients with active disease. 
In veterinary medicine, extraintestinal manifestations of IBD are rarely noticed (Guilford 
1996). Polyarthritis (Pedersen et al 1976, Bennet 2005), inflammatory hepatic disease, 
pancreatitis and nephritis (Weiss et al 1996) have been described in small animals. Pruritic 
concurrent skin diseases have also been reported (Guilford, 1996). These lesions could be due to 
the immune complex deposition in different organs, secondary to aberrant immunological 
responses in IBD, though the ethiopathogenesis of these signs is not well understood (Center 
1996). Thrombocytopenia and anaemia have also been described in dogs with IBD (Ridgway et 
al 2001, Ristic and Stidworthy 2002).  
In dogs, many diseases lead to prothrombotic tendencies. Diseases that cause endothelial 
damage, blood stasis or systemic hypercoagulability have a thromboembolic potential (Good and 
Manning 2003). The common methods used to assess hemostasis are more effective in 
documenting a trend toward hypocoagulability than one toward hypercoagulability (Good and 
Manning 2003). Although it is not used commonly in veterinary patients clinically yet, 
thromboelastography provides a method for identifying hypercoagulable patients (Goggs and 
others 2009). Hypercoagulability can be due to many factors, including decreased levels of 
Antithrombin III (ATIII). ATIII deficiency is common in glomerular diseases due to protein loss 
(DiBartola and Meuten 1980, Greco and Green 1987, Cook and Cowgill 1996, Ritt et al 1997). 
This deficiency may also occur in diseases causing protein loss through the gastrointestinal tract, 
like parvoviral enteritis (Otto et al 2000). Protein-losing enteropathies frequently allow the 
extravasation of larger proteins than in a protein-losing nephropathy. In this case, the haemostatic 
balance may not be altered because of the simultaneous loss of both large procoagulant factors 
and small anticoagulant factors in equal amounts (Green 1984). Therefore, protein-losing 
enteropathies could be less frequently involved with thromboembolic risk (Good and Manning 
2003). 
This could explain the limited information available in the literature about thrombotic 
events in dogs with protein-losing enteropathy. Femoral thrombosis has been previously 
described in a dog with intestinal lymphosarcoma and hypoproteinemia (Ihle et al 1996). Distal 
aortic thrombosis has also been reported in one case of protein-losing enteropathy (Clare and 
Kraje 1998). Interestingly, pulmonary thromboembolism was suspected in 2 Yorkshire terriers 
with protein-losing enteropathy (Kimmel et al 2000). To the author’s knowledge, this is the first 
clinical and pathological description of canine pulmonary thromboembolism associated with 
IBD.  
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Diseases most commonly associated with pulmonary thromboembolism in dogs are: 
heart disease (including heartworm disease), glomerular disease, neoplasia, disseminated 
intravascular coagulopathy, immune-mediated haemolytic anemia, pancreatitis, sepsis, trauma, 
hyperadrenocorticism, hypothyroidism, and diabetes mellitus (Burns et al 1981, Klein et al 1989, 
LaRue and Murtaugh 1990, Corlouer 1994, Kittleson and Kienle 1998, Good and Manning 
2003). Prothrombotic tendencies can be exacerbated by immunosuppressive therapy with 
corticosteroids (Good and Manning 2003). 
Pulmonary thromboembolism was not suspected in our case, due to the absence of 
clinical signs and abnormalities found in the physical examination compatible with this disease. 
These difficulties have also been described in human medicine. In a recent report, the most 
frequently underdiagnosed disease in human autopsies (in 61% of cases) was pulmonary 
thromboembolism (Ermenc 1999).  
Taking into account this case report and the incidence of thromboembolic events in 
human patients with IBD, further studies are required to investigate the rate of thromboembolism 
or hypercoagulability in dogs with inflammatory bowel disease.  
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